Cargando…
HGF/Met and FOXM1 Form a Positive Feedback Loop and Render Pancreatic Cancer Cells Resistance to Met Inhibition and Aggressive Phenotypes
PURPOSE: Hepatocyte growth factor (HGF)/Met signaling plays critical roles in pancreatic ductal adenocarcinoma (PDA) development and progression and is considered a potential therapeutic target for this disease. However, the mechanism of aberrant activation of HGF/Met signaling and resistance to Met...
Autores principales: | Cui, Jiujie, Xia, Tian, Xie, Dacheng, Gao, Yong, Jia, Zhiliang, Wei, Daoyan, Wang, Liang, Huang, Suyun, Quan, Ming, Xie, Keping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985506/ https://www.ncbi.nlm.nih.gov/pubmed/26876216 http://dx.doi.org/10.1038/onc.2016.14 |
Ejemplares similares
-
The roles of FOXM1 in pancreatic stem cells and carcinogenesis
por: Quan, Ming, et al.
Publicado: (2013) -
FoxM1 promotes breast tumorigenesis by activating PDGF-A and forming a positive feedback loop with the PDGF/AKT signaling pathway
por: Yu, Guanzhen, et al.
Publicado: (2015) -
Targeting HGF/c-MET Axis in Pancreatic Cancer
por: Pothula, Srinivasa P., et al.
Publicado: (2020) -
FOXM1 confers resistance to gefitinib in lung adenocarcinoma via a MET/AKT-dependent positive feedback loop
por: Wang, Yu, et al.
Publicado: (2016) -
HGF-MET as a breast cancer biomarker
por: Liu, Shuying
Publicado: (2015)